Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound sabal berry tablets for benign prostatic hyperplasia
ChiCTR1800015211Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of saw palmetto fruit extract in benign prostatic hyperplasia (BPH), sponsored by West China Hospital of Sichuan University. Primary endpoint: International Prostate Symptom Score at week 12. Started May 2009; status: completed.
02
Drugs
saw palmetto fruit extract
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR1800015211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015211.